Vera Therapeutics, Inc. (VERA) Misses Q1 EPS by 36c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $35.66 +4.18%
EPS Growth %: -27.8%
Financial Fact:
NET INCOME (LOSS): 20.17K
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: -27.8%
Financial Fact:
NET INCOME (LOSS): 20.17K
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q1 EPS of ($1.69), $0.36 worse than the analyst estimate of ($1.33).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kotak Starts Aequs Ltd (AEQUS:IN) at Reduce (3)
- Hewlett Packard Enterprise (HPE) Tops Q3 EPS by 19c; raises guidance
- Citi reiterates Buy rating on Baidu with $166 price target, Opens 30 Day Upside Catalyst Watch
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
